BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Idenix Pharmaceuticals, Inc. Reports Third Quarter and Nine Month 2009 Financial Results

  October 30, 2009

   · 

  5 min read
• Business

  Orexigen Therapeutics, Inc. Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009

  October 30, 2009

   · 

  1 min read
• Drug Development

  NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)'s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis

  October 30, 2009

   · 

  1 min read
• Pharm Country

  Company Profile for TechnoVax Inc.

  October 30, 2009

   · 

  1 min read
• Company Profile for Moritex Corporation

  October 30, 2009

   · 

  1 min read
• Bio NC

  INC Research, Inc. Leaders Receive Top Honors at the 2009 Clinical Research Excellence Awards

  October 30, 2009

   · 

  1 min read
• Pharm Country

  SIGA Technologies, Inc. Files $100 Million Shelf Registration

  October 30, 2009

   · 

  1 min read
• Business

  Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2010

  October 30, 2009

   · 

  1 min read
• Business

  Geron Corporation Reports 2009 Third Quarter Financial Results and Events

  October 30, 2009

   · 

  1 min read
• Business

  Nektar Therapeutics to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets

  October 30, 2009

   · 

  1 min read